FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Chris Reutelingsperger

Research Profile

Chemicals & Drugs

Living Beings

Mouse

Anatomy

Procedures

Physiology

Blood Coagulation

Disorders

Concepts & Ideas

Biological Markers

Co-author Network

Publications

TOP 3
Dennis H M Kusters; Leon J Schurgers; Jan Tegtmeier; Chris P M Reutelingsperger
Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice.
Christel Vangestel; Patrick Pauwels; Chris P M Reutelingsperger; Steven Staelens; Nancy Van Damme; Christophe Van De Wiele; Marc Peeters
(99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.
Hendrikus H Boersma; Hans J de Haas; Chris P M Reutelingsperger; Riemer H J A Slart
P-selectin imaging in cardiovascular disease: what you see is what you get?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Chris Reutelingsperger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Dennis H M Kusters; Leon J Schurgers; Jan Tegtmeier; Chris P M Reutelingsperger
Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2012;14(5):523-33.
2011: Christel Vangestel; Patrick Pauwels; Chris P M Reutelingsperger; Steven Staelens; Nancy Van Damme; Christophe Van De Wiele; Marc Peeters
(99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(11):1786-94.
2011: Hendrikus H Boersma; Hans J de Haas; Chris P M Reutelingsperger; Riemer H J A Slart
P-selectin imaging in cardiovascular disease: what you see is what you get?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(9):1337-8.
2011: Matthias Bauwens; Marijke De Saint-Hubert; Ellen Devos; Niko Deckers; Chris P M Reutelingsperger; Luc Mortelmans; Uwe Himmelreich; Felix M Mottaghy; Alfons Verbruggen
Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis.
Nuclear medicine and biology 2011;38(3):381-92.
2011: Lisette Ungethüm; Heidi Kenis; Gerry A Nicolaes; Ludovic Autin; Svetla Stoilova-McPhie; Chris P M Reutelingsperger
Engineered annexin A5 variants have impaired cell entry for molecular imaging of apoptosis using pretargeting strategies.
The Journal of biological chemistry 2011;286(3):1903-10.
2010: Geralda A F van Tilborg; Esad Vucic; Gustav J Strijkers; David P Cormode; Venkatesh Mani; Torjus Skajaa; Chris P M Reutelingsperger; Zahi A Fayad; Willem J M Mulder; Klaas Nicolay
Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques.
Bioconjugate chemistry 2010;21(10):1794-803.
2010: Kristof Schutters; Chris P M Reutelingsperger
Phosphatidylserine targeting for diagnosis and treatment of human diseases.
Apoptosis : an international journal on programmed cell death 2010;15(9):1072-82.
2010: Reint K Jellema; Paul Bomans; Niko Deckers; Liset Ungethum; Chris P M Reutelingsperger; Leo Hofstra; Peter M Frederik
Transfection efficiency of lipoplexes for site-directed delivery.
Journal of liposome research 2010;20(3):258-67.
2010: Heidi Kenis; Harmen Reinier Zandbergen; Leo Hofstra; Artiom D Petrov; Ewald A W J Dumont; Francis D Blankenberg; Nezam Haider; Nicole Bitsch; Marion J J Gijbels; Johan W H Verjans; Navneet Narula; Jagat Narula; Chris P M Reutelingsperger
Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(2):259-67.
2010: Marijke De Saint-Hubert; Felix M Mottaghy; Kathleen Vunckx; Johan Nuyts; Humphrey Fonge; Kristof Prinsen; Sigrid Stroobants; Luc Mortelmans; Niko Deckers; Leo Hofstra; Chris P M Reutelingsperger; Alfons Verbruggen; Dirk Rattat
Site-specific labeling of 'second generation' annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo.
Bioorganic & medicinal chemistry 2010;18(3):1356-63.
2010: Gustav J Strijkers; Geralda A F van Tilborg; Tessa Geelen; Chris P M Reutelingsperger; Klaas Nicolay
Current applications of nanotechnology for magnetic resonance imaging of apoptosis.
Methods in molecular biology (Clifton, N.J.) 2010;624():325-42.
2009: Nezam Haider; Dagmar Hartung; Shinichiro Fujimoto; Artiom Petrov; Frank D Kolodgie; Renu Virmani; Satoru Ohshima; Han Liu; Jun Zhou; Ai Fujimoto; Atsuko Tahara; Leo Hofstra; Navneet Narula; Chris P M Reutelingsperger; Jagat Narula
Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2009;16(5):753-62.
2009: Kim Douma; Lenneke Prinzen; Dick W Slaaf; Chris P M Reutelingsperger; Erik A L Biessen; Tilman M Hackeng; Mark J Post; Marc A M J van Zandvoort
Nanoparticles for optical molecular imaging of atherosclerosis.
Small (Weinheim an der Bergstrasse, Germany) 2009;5(5):544-57.
2009: Susanne W M van den Borne; Satoshi Isobe; H Reinier Zandbergen; Peng Li; Artiom Petrov; Nathan D Wong; Shinichiro Fujimoto; Ai Fujimoto; Dagfinn Lovhaug; Jos F M Smits; Mat J A P Daemen; W Matthijs Blankesteijn; Chris P M Reutelingsperger; Faiez Zannad; Navneet Narula; Mani A Vannan; Bertram Pitt; Leo Hofstra; Jagat Narula
Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling.
JACC. Cardiovascular imaging 2009;2(2):187-98.
2009: Heidi Kenis; Chris P M Reutelingsperger
Targeting phosphatidylserine in anti-cancer therapy.
Current pharmaceutical design 2009;15(23):2719-23.
2009: Geralda A F van Tilborg; Tessa Geelen; Hans Duimel; Paul H H Bomans; Peter M Frederik; Honorius M H F Sanders; Niko Deckers; Roel Deckers; Chris P M Reutelingsperger; Gustav J Strijkers; Klaas Nicolay
Internalization of annexin A5-functionalized iron oxide particles by apoptotic Jurkat cells.
Contrast media & molecular imaging 2009;4(1):24-32.
2008: Susanne W M van den Borne; Satoshi Isobe; Johan W Verjans; Artiom Petrov; Dagfinn Lovhaug; Peng Li; H Reinier Zandbergen; Youping Ni; Peter Frederik; Jun Zhou; Bente Arbo; Astri Rogstad; Alan Cuthbertson; Salah Chettibi; Chris P M Reutelingsperger; W Matthijs Blankesteijn; Jos F M Smits; Mat J A P Daemen; Faiez Zannad; Mani A Vannan; Navneet Narula; Bertram Pitt; Leo Hofstra; Jagat Narula
Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction.
Journal of the American College of Cardiology 2008;52(24):2017-28.
2008: Geralda A F van Tilborg; Willem J M Mulder; Daisy W J van der Schaft; Chris P M Reutelingsperger; Arjan W Griffioen; Gustav J Strijkers; Klaas Nicolay
Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes.
Neoplasia (New York, N.Y.) 2008;10(12):1459-69.
2008: Geralda A F van Tilborg; Gustav J Strijkers; Emilie M Pouget; Chris P M Reutelingsperger; Nico Sommerdijk; Klaas Nicolay; Willem J M Mulder
Kinetics of avidin-induced clearance of biotinylated bimodal liposomes for improved MR molecular imaging.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2008;60(6):1444-56.
2008: Hugo O van Genderen; Heidi Kenis; Leo Hofstra; Jagat Narula; Chris P M Reutelingsperger
Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization.
Biochimica et biophysica acta 2008;1783(6):953-63.
2008: Johan W H Verjans; Dagfinn Lovhaug; Navneet Narula; Artiom D Petrov; Bård Indrevoll; Emma Bjurgert; Tatiana B Krasieva; Lizette B Petersen; Grete M Kindberg; Magne Solbakken; Alan Cuthbertson; Mani A Vannan; Chris P M Reutelingsperger; Bruce J Tromberg; Leonard Hofstra; Jagat Narula
Noninvasive imaging of angiotensin receptors after myocardial infarction.
JACC. Cardiovascular imaging 2008;1(3):354-62.
2008: Marijke J E Kuijpers; Imke C A Munnix; Judith M E M Cosemans; Bart Van Vlijmen; Chris P M Reutelingsperger; mirjam oude egbrink; Johan W M Heemskerk
Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.
Microcirculation (New York, N.Y. : 1994) 2008;15(4):269-82.
2008: Edward M Laufer; Chris P M Reutelingsperger; Jagat Narula; Leo Hofstra
Annexin A5: an imaging biomarker of cardiovascular risk.
Basic research in cardiology 2008;103(2):95-104.
2007: Masayoshi Sarai; Dagmar Hartung; Artiom Petrov; Jun Zhou; Navneet Narula; Leo Hofstra; Frank D Kolodgie; Satoshi Isobe; Shinichiro Fujimoto; Jean-Luc Vanderheyden; Renu Virmani; Chris P M Reutelingsperger; Nathan D Wong; Sudhir Gupta; Jagat Narula
Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging.
Journal of the American College of Cardiology 2007;50(24):2305-12.
2007: Simone J H Wielders; Lisette Ungethüm; Chris P M Reutelingsperger; Edouard M Bevers; Theo Lindhout
Factor Xa-driven thrombin generation in plasma: dependency on the aminophospholipid density of membranes and inhibition by phospholipid-binding proteins.
Thrombosis and haemostasis 2007;98(5):1056-62.
2007: Heidi Kenis; Leo Hofstra; Chris P M Reutelingsperger
Annexin A5: shifting from a diagnostic towards a therapeutic realm.
Cellular and molecular life sciences : CMLS 2007;64(22):2859-62.
2007: Arseni Markoff; Nadja Bogdanova; Markus Knop; Claas Rüffer; Heidi Kenis; Petra Lux; Chris P M Reutelingsperger; Vassil Todorov; Bernd Dworniczak; Jürgen Horst; Volker Gerke
Annexin A5 interacts with polycystin-1 and interferes with the polycystin-1 stimulated recruitment of E-cadherin into adherens junctions.
Journal of molecular biology 2007;369(4):954-66.
2007: Stephanie Züllig; Lukas J Neukomm; Marko Jovanovic; Steve J Charette; Nicholas N Lyssenko; Margaret S Halleck; Chris P M Reutelingsperger; Robert A Schlegel; Michael O. Hengartner
Aminophospholipid translocase TAT-1 promotes phosphatidylserine exposure during C. elegans apoptosis.
Current biology : CB 2007;17(11):994-9.
2007: S L Wolters; Maarten F Corsten; Chris P M Reutelingsperger; Jagat Narula; Leo Hofstra
Cardiovascular molecular imaging of apoptosis.
European journal of nuclear medicine and molecular imaging 2007;34 Suppl 1():S86-98.
2007: Dagmar Hartung; Michael Schäfers; Shinichiro Fujimoto; Bodo Levkau; Navneet Narula; Klaus Kopka; Renu Virmani; Chris P M Reutelingsperger; Leo Hofstra; Frank D Kolodgie; Artiom Petrov; Jagat Narula
Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions.
European journal of nuclear medicine and molecular imaging 2007;34 Suppl 1():S1-8.
2007: Bas L J H Kietselaer; Chris P M Reutelingsperger; Hendrikus H Boersma; Guido A K Heidendal; Ing Han Liem; Harry J G M Crijns; Jagat Narula; Leo Hofstra
Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):562-7.
2007: Simone J H Wielders; Abdelkader Bennaghmouch; Chris P M Reutelingsperger; Edouard M Bevers; Theo Lindhout
Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists.
Journal of thrombosis and haemostasis : JTH 2007;5(3):571-6.
2007: Maarten F Corsten; Chris P M Reutelingsperger; Leo Hofstra
Imaging apoptosis for detecting plaque instability: rendering death a brighter facade.
Current opinion in biotechnology 2007;18(1):83-9.
2007: Lenneke Prinzen; Robbert-Jan J H M Miserus; Anouk Dirksen; Tilman M Hackeng; Niko Deckers; Nicole J Bitsch; remco TA megens; Kim Douma; Johan W M Heemskerk; M Eline Kooi; Peter M Frederik; Dick W Slaaf; Marc A M J van Zandvoort; Chris P M Reutelingsperger
Optical and magnetic resonance imaging of cell death and platelet activation using annexin a5-functionalized quantum dots.
Nano letters 2007;7(1):93-100.
2006: Xiao-Xuan Wu; Alan A Arslan; Rosemary Wein; Chris P M Reutelingsperger; Charles J Lockwood; Edward Kuczynski; Jacob H Rand
Analysis of circulating annexin A5 parameters during pregnancy: absence of differences between women with recurrent spontaneous pregnancy losses and controls.
American journal of obstetrics and gynecology 2006;195(4):971-8.
2006: Satoshi Isobe; Sotirios Tsimikas; Jun Zhou; Shinichiro Fujimoto; Masayoshi Sarai; Michael J Branks; Ai Fujimoto; Leo Hofstra; Chris P M Reutelingsperger; Toyoaki Murohara; Renu Virmani; Frank D Kolodgie; Navneet Narula; Artiom Petrov; Jagat Narula
Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(9):1497-505.
2006: Geralda A F van Tilborg; Willem J M Mulder; Patrick T K Chin; Gert Storm; Chris P M Reutelingsperger; Klaas Nicolay; Gustav J Strijkers
Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells.
Bioconjugate chemistry 2006;17(4):865-8.
2006: Hugo van Genderen; Simone J H Wielders; Theo Lindhout; Chris P M Reutelingsperger
Rolling and adhesion of apoptotic monocytes is impaired by loss of functional cell surface-expressed P-selectin glycoprotein ligand-1.
Journal of thrombosis and haemostasis : JTH 2006;4(7):1611-7.
2006: Geralda A F van Tilborg; Willem J M Mulder; Niko Deckers; Gert Storm; Chris P M Reutelingsperger; Gustav J Strijkers; Klaas Nicolay
Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis.
Bioconjugate chemistry 2006;17(3):741-9.
2006: Heidi Kenis; Hugo van Genderen; Niko Deckers; Petra Lux; Leo Hofstra; Jagat Narula; Chris P M Reutelingsperger
Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches.
Experimental cell research 2006;312(6):719-26.
2006: Maarten F Corsten; Leo Hofstra; Jagat Narula; Chris P M Reutelingsperger
Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance.
Cancer research 2006;66(3):1255-60.
2006: Hugo van Genderen; Heidi Kenis; Petra Lux; Lisette Ungeth; Cecile Maassen; Niko Deckers; Jagat Narula; Leo Hofstra; Chris P M Reutelingsperger
In vitro measurement of cell death with the annexin A5 affinity assay.
Nature protocols 2006;1(1):363-7.
2006: Jacob H Rand; Alan A Arslan; Xiao-Xuan Wu; Rosemary Wein; Jeanine Mulholland; Manish Shah; Waander L van Heerde; Chris P M Reutelingsperger; Charles J Lockwood; Edward Kuczynski
Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses.
American journal of obstetrics and gynecology 2006;194(1):182-8.
2005: Dagmar Hartung; Masayoshi Sarai; Artiom Petrov; Frank D Kolodgie; Navneet Narula; Johan W Verjans; Renu Virmani; Chris P M Reutelingsperger; Leo Hofstra; Jagat Narula
Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2051-6.
2005: Hendrikus H Boersma; Bas L J H Kietselaer; Leo M L Stolk; Abdelkader Bennaghmouch; Leo Hofstra; Jagat Narula; Guido A K Heidendal; Chris P M Reutelingsperger
Past, present, and future of annexin A5: from protein discovery to clinical applications.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2035-50.
2005: Leon J Schurgers; Kirsten J F Teunissen; Marjo H J Knapen; Martijn Kwaijtaal; Rob van Diest; Ad Appels; Chris P M Reutelingsperger; Jack P M Cleutjens; Cees Vermeer
Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(8):1629-33.
2005: Sudhir Gupta; Chris P M Reutelingsperger; Jagat Narula
Mortals turn me on...
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):906-8.
2005: Kiyoko Asai; Wim A Buurman; Chris P M Reutelingsperger; Bert Schutte; Michio Kaminishi
Modular effects of estradiol on ethanol-induced apoptosis in human intestinal epithelial cells.
Scandinavian journal of gastroenterology 2005;40(3):326-35.
2005: Susana Ravassa; Abdelkader Bennaghmouch; Heidi Kenis; Theo Lindhout; Tilman M Hackeng; Jagat Narula; Leo Hofstra; Chris P M Reutelingsperger
Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoir.
The Journal of biological chemistry 2005;280(7):6028-35.
2004: Heidi Kenis; Hugo van Genderen; Abdelkader Bennaghmouch; Hilde A Rinia; Peter M Frederik; Jagat Narula; Leo Hofstra; Chris P M Reutelingsperger
Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry.
The Journal of biological chemistry 2004;279(50):52623-9.
2004: Jacob H Rand; Xiao-Xuan Wu; Robert Lapinski; Waander L van Heerde; Chris P M Reutelingsperger; Pojen P Chen; Thomas L Ortel
Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome.
Blood 2004;104(9):2783-90.
2004: Chris P M Reutelingsperger; Leo Hofstra; Jagat Narula
Cooking annexin V: a simple 1-pot procedure to destroy its phosphatidylserine-binding activity.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(6):1098; author reply 1098-9.
2004: Bas L J H Kietselaer; Chris P M Reutelingsperger; Guido A K Heidendal; Mat J A P Daemen; Werner H Mess; Leo Hofstra; Jagat Narula
Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis.
The New England journal of medicine 2004;350(14):1472-3.
2004: Hendrikus H Boersma; Leo M L Stolk; Heidi Kenis; Niko Deckers; Jean-Luc Vanderheyden; Leo Hofstra; Guido A K Heidendal; Chris P M Reutelingsperger
The ApoCorrect assay: a novel, rapid method to determine the biological functionality of radiolabeled and fluorescent Annexin A5.
Analytical biochemistry 2004;327(1):126-34.
2003: Frank D Kolodgie; Artiom Petrov; Renu Virmani; Navneet Narula; Johan W Verjans; Deena K Weber; Dagmar Hartung; Neil Steinmetz; Jean-Luc Vanderheyden; Mani A Vannan; Herman K Gold; Chris P M Reutelingsperger; Leo Hofstra; Jagat Narula
Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque.
Circulation 2003;108(25):3134-9.
2003: Bas L J H Kietselaer; Leo Hofstra; Ewald A W J Dumont; Chris P M Reutelingsperger; Guido A K Heidendal
The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2003;47(4):349-61.
2003: Heidi Kenis; C J M Doggen; Hans L Vos; Chris P M Reutelingsperger; W L vn Heerde
The C-1T mutation in the annexin A5 Kozak sequence slightly increases the risk of myocardial infarction in men.
Journal of thrombosis and haemostasis : JTH 2003;1(12):2688-9.
2003: K Asai; Wim A Buurman; Chris P M Reutelingsperger; Bert Schutte; M Kaminishi
Low concentrations of ethanol induce apoptosis in human intestinal cells.
Scandinavian journal of gastroenterology 2003;38(11):1154-61.
2003: Kristin Verbeke; davy Kieffer; Jean-Luc Vanderheyden; Chris P M Reutelingsperger; Neil Steinmetz; Allan Green; Alfons Verbruggen
Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human use.
Nuclear medicine and biology 2003;30(7):771-8.
2003: Shaila Garg; Leo Hofstra; Chris P M Reutelingsperger; Jagat Narula
Apoptosis as a therapeutic target in acutely ischemic myocardium.
Current opinion in cardiology 2003;18(5):372-7.
2003: Robbert G E Notenboom; Marius A van den Bergh Weerman; Koert P Dingemans; Jacqueline L M Vermeulen; Stefan M van den Eijnde; Chris P M Reutelingsperger; Hans Hut; Rob Willemsen; G Johan A Offerhaus; Wouter H Lamers
Timing and sequence of differentiation of embryonic rat hepatocytes along the biliary epithelial lineage.
Hepatology (Baltimore, Md.) 2003;38(3):683-91.
2003: Hendrikus H Boersma; Ing Han Liem; Gerrit J Kemerink; Paul W L Thimister; Leo Hofstra; Leo M L Stolk; Waander L van Heerde; M-T W Pakbiers; D Janssen; AJ Beysens; Chris P M Reutelingsperger; Guido A K Heidendal
Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5.
The British journal of radiology 2003;76(908):553-60.
2003: Waander L van Heerde; Heidi Kenis; Selene Schoormans; Paul Lap; Chris P M Reutelingsperger
The -1C>T mutation in the annexin A5 gene does not affect plasma levels of annexin A5.
Blood 2003;101(10):4223-4; author reply 4224-5.
2003: Waander L van Heerde; Chris P M Reutelingsperger; C Maassen; Petra Lux; R H W M Derksen; Philip G de Groot
The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasma.
Journal of thrombosis and haemostasis : JTH 2003;1(3):532-6.
2003: Paul W L Thimister; Leo Hofstra; Ing Han Liem; Hendrikus H Boersma; Gerrit J Kemerink; Chris P M Reutelingsperger; Guido A K Heidendal
In vivo detection of cell death in the area at risk in acute myocardial infarction.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(3):391-6.
2003: Ewald A W J Dumont; Chris P M Reutelingsperger; Guido A K Heidendal; Leo Hofstra
Bringing cell death alive.
Cardiovascular toxicology 2003;3(3):207-18.
2002: J G M C Damoiseaux; M P Defresne; Chris P M Reutelingsperger; Peter J C van Breda Vriesman
Cyclosporin-A differentially affects apoptosis during in vivo rat thymocyte maturation.
Scandinavian journal of immunology 2002;56(4):353-60.
2002: Patrick W Weerwind; N E H Caberg; Chris P M Reutelingsperger; Theo Lindhout; Dick S de Jong
Exposure of procoagulant phospholipids on the surface of platelets in patients undergoing cardiopulmonary bypass using non-coated and heparin-coated extracorporeal circuits.
The International journal of artificial organs 2002;25(8):770-6.
2002: Erik J Fransen; Eva Rombout-Sestrienkova; Elisabeth C M van Pampus; Wim A Buurman; Chris P M Reutelingsperger; Jos G Maessen
Prestorage leucocyte reduction of red cell components prevents release of bactericidal permeability increasing protein and defensins.
Vox sanguinis 2002;83(2):119-24.
2002: Chris P M Reutelingsperger; Ewald A W J Dumont; Paul W L Thimister; Hugo van Genderen; Heidi Kenis; Stefan van de Eijnde; Guido A K Heidendal; Leo Hofstra
Visualization of cell death in vivo with the annexin A5 imaging protocol.
Journal of immunological methods 2002;265(1-2):123-32.
2001: E A Dumont; Chris P M Reutelingsperger; Jos F M Smits; M J Daemen; Pieter A Doevendans; Hein J J Wellens; Leo Hofstra
Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart.
Nature medicine 2001;7(12):1352-5.
2001: Stefan M van den Eijnde; M J van den Hoff; Chris P M Reutelingsperger; Waander L van Heerde; Mieke Henfling; Christl Vermeij-Keers; Bert Schutte; Marcel Borgers; Frans C S Ramaekers
Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation.
Journal of cell science 2001;114(Pt 20):3631-42.
2001: Gerrit J Kemerink; Hendrikus H Boersma; Paul W L Thimister; Leo Hofstra; Ing Han Liem; M-T W Pakbiers; D Janssen; Chris P M Reutelingsperger; Guido A K Heidendal
Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
European journal of nuclear medicine 2001;28(9):1373-8.
2001: Chris P M Reutelingsperger
Annexins: key regulators of haemostasis, thrombosis, and apoptosis.
Thrombosis and haemostasis 2001;86(1):413-9.
2001: Leo Hofstra; Ewald A W J Dumont; Paul W L Thimister; Guido A K Heidendal; A P DeBruine; T W Elenbaas; Hendrikus H Boersma; Waander L van Heerde; Chris P M Reutelingsperger
In vivo detection of apoptosis in an intracardiac tumor.
JAMA : the journal of the American Medical Association 2001;285(14):1841-2.
2001: Gerrit J Kemerink; Ing Han Liem; Leo Hofstra; Hendrikus H Boersma; Wilhelmina C A M Buijs; Chris P M Reutelingsperger; Guido A K Heidendal
Patient dosimetry of intravenously administered 99mTc-annexin V.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(2):382-7.
2001: M Engeland; S M van den Eijnde; T Aken; C Vermeij-Keers; Frans C S Ramaekers; Bert Schutte; Chris P M Reutelingsperger
Detection of apoptosis in ovarian cells in vitro and in vivo using the annexin v-affinity assay.
Methods in molecular medicine 2001;39():669-77.
2000: Ewald A W J Dumont; Leo Hofstra; Waander L van Heerde; Stefan M van den Eijnde; Pieter A Doevendans; E DeMuinck; M A Daemen; Jos F M Smits; Peter M Frederik; Hein J J Wellens; Mat J A P Daemen; Chris P M Reutelingsperger
Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model.
Circulation 2000;102(13):1564-8.
2000: Istvan Vermes; Clemens Haanen; Chris P M Reutelingsperger
Flow cytometry of apoptotic cell death.
Journal of immunological methods 2000;243(1-2):167-90.
2000: Antonius L J J Bronckers; W Goei; Waander L van Heerde; Ewald A W J Dumont; Chris P M Reutelingsperger; Stefan M van den Eijnde
Phagocytosis of dying chondrocytes by osteoclasts in the mouse growth plate as demonstrated by annexin-V labelling.
Cell and tissue research 2000;301(2):267-72.
2000: Leo Hofstra; Ing Han Liem; Ewald A W J Dumont; Hendrikus H Boersma; Waander L van Heerde; Pieter A Doevendans; Ebo D de Muinck; Hein J J Wellens; Gerrit J Kemerink; Chris P M Reutelingsperger; Guido A K Heidendal
Visualisation of cell death in vivo in patients with acute myocardial infarction.
Lancet 2000;356(9225):209-12.
2000: D Terwel; LJ Nieland; Bert Schutte; Chris P M Reutelingsperger; Frans C S Ramaekers; Harry W M Steinbusch
S-nitroso-N-acetylpenicillamine and nitroprusside induce apoptosis in a neuronal cell line by the production of different reactive molecules.
European journal of pharmacology 2000;400(1):19-33.
2000: Antonius L J J Bronckers; SW Goei; Ewald A W J Dumont; Donacian M Lyaruu; Joseph H M Wöltgens; Waander L van Heerde; Chris P M Reutelingsperger; Stefan M van den Eijnde
In situ detection of apoptosis in dental and periodontal tissues of the adult mouse using annexin-V-biotin.
Histochemistry and cell biology 2000;113(4):293-301.
2000: Waander L van Heerde; S Robert-Offerman; Ewald A W J Dumont; Leo Hofstra; Pieter A Doevendans; Jos F M Smits; Mat J A P Daemen; Chris P M Reutelingsperger
Markers of apoptosis in cardiovascular tissues: focus on Annexin V.
Cardiovascular research 2000;45(3):549-59.
1999: R Overbeeke; M Yildirim; Chris P M Reutelingsperger; Clemens Haanen; Istvan Vermes
Sequential occurrence of mitochondrial and plasma membrane alterations, fluctuations in cellular Ca2+ and pH during initial and later phases of cell death.
Apoptosis : an international journal on programmed cell death 1999;4(6):455-60.
1999: Istvan Vermes; Ernst N H Jansen Steur; Chris P M Reutelingsperger; Clemens Haanen
Decreased concentration of annexin V in parkinsonian cerebrospinal fluid: speculation on the underlying cause.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):1008-10.
1999: Johan W M Heemskerk; Pia R-M Siljander; Wim M J Vuist; Githa Breikers; Chris P M Reutelingsperger; Michael J Barnes; C Graham Knight; Riitta Lassila; Richard W Farndale
Function of glycoprotein VI and integrin alpha2beta1 in the procoagulant response of single, collagen-adherent platelets.
Thrombosis and haemostasis 1999;81(5):782-92.
1999: M Robers; Irma Rensink; C Erik Hack; L A Aarden; Chris P M Reutelingsperger; Jan F C Glatz; Wim T Hermens
A new principle for rapid immunoassay of proteins based on in situ precipitate-enhanced ellipsometry.
Biophysical journal 1999;76(5):2769-76.
1999: Stefan M van den Eijnde; J Lips; L Boshart; Christl Vermeij-Keers; E Marani; Chris P M Reutelingsperger; Chris I De Zeeuw
Spatiotemporal distribution of dying neurons during early mouse development.
The European journal of neuroscience 1999;11(2):712-24.
1998: Marc Stuart; Chris P M Reutelingsperger; Peter M Frederik
Binding of annexin V to bilayers with various phospholipid compositions using glass beads in a flow cytometer.
Cytometry 1998;33(4):414-9.
1998: Marc Stuart; J G Damoiseaux; Peter M Frederik; JW Arends; Chris P M Reutelingsperger
Surface exposure of phosphatidylserine during apoptosis of rat thymocytes precedes nuclear changes.
European journal of cell biology 1998;76(1):77-83.
1998: R Overbeeke; H Steffens-Nakken; Istvan Vermes; Chris P M Reutelingsperger; Clemens Haanen
Early features of apoptosis detected by four different flow cytometry assays.
Apoptosis : an international journal on programmed cell death 1998;3(2):115-21.
1998: Stefan M van den Eijnde; L Boshart; E H Baehrecke; Chris I De Zeeuw; Chris P M Reutelingsperger; Christl Vermeij-Keers
Cell surface exposure of phosphatidylserine during apoptosis is phylogenetically conserved.
Apoptosis : an international journal on programmed cell death 1998;3(1):9-16.
1998: Henk-Jan Guchelaar; Istvan Vermes; R P Koopmans; Chris P M Reutelingsperger; Clemens Haanen
Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model.
Cancer chemotherapy and pharmacology 1998;42(1):77-83.
1998: SW Jans; YF de Jong; Chris P M Reutelingsperger; Ger J van der Vusse; Marc van Bilsen
Differential expression and localization of annexin V in cardiac myocytes during growth and hypertrophy.
Molecular and cellular biochemistry 1998;178(1-2):229-36.
1998: C A Idink-Mecking; DJ Richel; Istvan Vermes; MR Schaafsma; Chris P M Reutelingsperger; Clemens Haanen
Ex vivo evidence of lymphocyte apoptosis in hairy cell leukemia, induced by 2-chlorodeoxyadenosine treatment.
Annals of hematology 1998;76(1):25-9.
1998: Manon van Engeland; LJ Nieland; Frans C S Ramaekers; Bert Schutte; Chris P M Reutelingsperger
Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.
Cytometry 1998;31(1):1-9.
1997: Stefan M van den Eijnde; A J M Luijsterburg; L Boshart; Chris I De Zeeuw; J H van Dierendonck; Chris P M Reutelingsperger; Christl Vermeij-Keers
In situ detection of apoptosis during embryogenesis with annexin V: from whole mount to ultrastructure.
Cytometry 1997;29(4):313-20.
1997: Johan W M Heemskerk; Wim M J Vuist; Marion A H Feijge; Chris P M Reutelingsperger; Theo Lindhout
Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses.
Blood 1997;90(7):2615-25.
1997: Manon van Engeland; Helma J H Kuijpers; Frans C S Ramaekers; Chris P M Reutelingsperger; Bert Schutte
Plasma membrane alterations and cytoskeletal changes in apoptosis.
Experimental cell research 1997;235(2):421-30.
1997: Chris P M Reutelingsperger; Waander L van Heerde
Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis.
Cellular and molecular life sciences : CMLS 1997;53(6):527-32.
1997: Stefan M van den Eijnde; L Boshart; Chris P M Reutelingsperger; Chris I De Zeeuw; Christl Vermeij-Keers
Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis.
Cell death and differentiation 1997;4(4):311-6.
1997: SW Jans; J Willems; Marc van Bilsen; Chris P M Reutelingsperger; Ger J van der Vusse
Phospholipid degradation in energy-deprived cardiac myocytes: does annexin V play a role?
Journal of molecular and cellular cardiology 1997;29(5):1401-10.
1997: Han Speijer; SW Jans; Chris P M Reutelingsperger; C Erik Hack; Ger J van der Vusse; Wim T Hermens
Partial coverage of phospholipid model membranes with annexin V may completely inhibit their degradation by phospholipase A2.
FEBS letters 1997;402(2-3):193-7.
1997: Istvan Vermes; Clemens Haanen; DJ Richel; MR Schaafsma; E Kalsbeek-Batenburg; Chris P M Reutelingsperger
Apoptosis and secondary necrosis of lymphocytes in culture.
Acta haematologica 1997;98(1):8-13.
1996: Manon van Engeland; Frans C S Ramaekers; Bert Schutte; Chris P M Reutelingsperger
A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture.
Cytometry 1996;24(2):131-9.
1996: S C van IJzendoorn; R G van Gool; Chris P M Reutelingsperger; Johan W M Heemskerk
Unstimulated platelets evoke calcium responses in human umbilical vein endothelial cells.
Biochimica et biophysica acta 1996;1311(1):64-70.
1995: Marc Stuart; E M Bevers; P Comfurius; R F Zwaal; Chris P M Reutelingsperger; Peter M Frederik
Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets.
Thrombosis and haemostasis 1995;74(4):1145-51.
1995: Istvan Vermes; Clemens Haanen; H Steffens-Nakken; Chris P M Reutelingsperger
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.
Journal of immunological methods 1995;184(1):39-51.
1995: E L Goossens; Chris P M Reutelingsperger; F H Jongsma; R Kraayenhof; Wim T Hermens
Annexin V perturbs or stabilises phospholipid membranes in a calcium-dependent manner.
FEBS letters 1995;359(2-3):155-8.
1995: W L van Heerde; Philip G de Groot; Chris P M Reutelingsperger
The complexity of the phospholipid binding protein Annexin V.
Thrombosis and haemostasis 1995;73(2):172-9.
1995: S W Jans; Marc van Bilsen; Chris P M Reutelingsperger; Marcel Borgers; Y F de Jong; Ger J van der Vusse
Annexin V in the adult rat heart: isolation, localization and quantitation.
Journal of molecular and cellular cardiology 1995;27(1):335-48.
1994: W L van Heerde; S Poort; C van 't Veer; Chris P M Reutelingsperger; Philip G de Groot
Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation.
The Biochemical journal 1994;302 ( Pt 1)():305-12.
1994: Chris P M Reutelingsperger
The annexins.
Lupus 1994;3(4):213-6.
1994: Chris P M Reutelingsperger; W van Heerde; R Hauptmann; C Maassen; R G van Gool; P de Leeuw; A Tiebosch
Differential tissue expression of Annexin VIII in human.
FEBS letters 1994;349(1):120-4.
1994: W L van Heerde; K S Sakariassen; Coenraad Hemker; Jan J Sixma; Chris P M Reutelingsperger; Philip G de Groot
Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(5):824-30.
1993: H A Andree; George M Willems; R Hauptmann; I Maurer-Fogy; Marc Stuart; Wim T Hermens; Peter M Frederik; Chris P M Reutelingsperger
Aggregation of phospholipid vesicles by a chimeric protein with the N-terminus of annexin I and the core of annexin V.
Biochemistry 1993;32(17):4634-40.
1992: Marc van Bilsen; Chris P M Reutelingsperger; Peter H M Willemsen; Robert S Reneman; Ger J van der Vusse
Annexins in cardiac tissue: cellular localization and effect on phospholipase activity.
Molecular and cellular biochemistry 1992;116(1-2):95-101.
1992: H A Andree; Marc Stuart; Wim T Hermens; Chris P M Reutelingsperger; Coenraad Hemker; Peter M Frederik; George M Willems
Clustering of lipid-bound annexin V may explain its anticoagulant effect.
The Journal of biological chemistry 1992;267(25):17907-12.
1992: Theo Lindhout; R Blezer; P Schoen; O Nordfang; Chris P M Reutelingsperger; Coenraad Hemker
Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells.
Blood 1992;79(11):2909-16.
1992: P Schoen; Chris P M Reutelingsperger; Theo Lindhout
Activation of prothrombin in the presence of human umbilical-vein endothelial cells.
The Biochemical journal 1992;281 ( Pt 3)():661-4.
1990: H A Andree; Chris P M Reutelingsperger; R Hauptmann; Coenraad Hemker; Wim T Hermens; George M Willems
Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers.
The Journal of biological chemistry 1990;265(9):4923-8.
1989: R Hauptmann; I Maurer-Fogy; E Krystek; G Bodo; H Andree; Chris P M Reutelingsperger
Vascular anticoagulant beta: a novel human Ca2+/phospholipid binding protein that inhibits coagulation and phospholipase A2 activity. Its molecular cloning, expression and comparison with VAC-alpha.
European journal of biochemistry / FEBS 1989;185(1):63-71.
1988: I Maurer-Fogy; Chris P M Reutelingsperger; J Pieters; G Bodo; C Stratowa; R Hauptmann
Cloning and expression of cDNA for human vascular anticoagulant, a Ca2+-dependent phospholipid-binding protein.
European journal of biochemistry / FEBS 1988;174(4):585-92.
1988: Chris P M Reutelingsperger; J M Kop; Gerard Hornstra; Coenraad Hemker
Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids.
European journal of biochemistry / FEBS 1988;173(1):171-8.